semaglutide novo nordisk Nordisk's diabetes and weight loss drug sales growth decelerates Ozempic | American Diabetes Association

GLP-1 in higher amounts also interacts with the parts of the brain that suppress your appetite and signal you to feel full

Some plans require step therapy, which forces patients to prove that less expensive medications were ineffective before they cover more costly ones

This trend is driven by a growing awareness of the compound's role in combating oxidative stress, which contributes to aging and various health issues

Drug Type Analysis The prescription drugs segment held the largest share in the anti-obesity drugs market with 82.3% share in 2024, primarily driven by the increasing demand for clinically proven weight management solutions